Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial - Wikidata - wikimedia - TriplyDB

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial

http://www.wikidata.org/entity/Q30407465

about

Interventions for idiopathic intracranial hypertension The diagnosis and management of idiopathic intracranial hypertension and the associated headache Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.The idiopathic intracranial hypertension treatment trial: clinical profile at baseline Therapeutic approaches to pediatric pseudotumor cerebri: New insights from literature data.Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability Idiopathic intracranial hypertension in the Middle East: A growing concern Applications of optical coherence tomography in pediatric clinical neuroscience.Headache determines quality of life in idiopathic intracranial hypertension.Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results.Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension Retinal and Choroidal Folds in Papilledema.Papilledema associated with puberty.Clarithromycin Culprit of Benign Intracranial Hypertension Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension.Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension.Neuroimaging Features of Idiopathic Intracranial Hypertension Persist After Resolution of Papilloedema.Idiopathic intracranial hypertension presenting as postpartum headache Bariatric Surgery or Non-surgical Weight Loss for Idiopathic Intracranial Hypertension? A Systematic Review and Comparison of Meta-analyses.New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.Headache and the pseudotumor cerebri syndrome.The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.Acetazolamide for the treatment of idiopathic intracranial hypertension.The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.Visual discrimination training improves Humphrey perimetry in chronic cortically induced blindness.The impact of ocular hemodynamics and intracranial pressure on intraocular pressure during acute gravitational changes.Idiopathic intracranial hypertension: Contemporary review and implications for the otolaryngologist.Decreased levels of aquaporin-4 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.Optic Nerve.Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management.A Possible Role for Temporary Lumbar Drainage in the Management of Idiopathic Intracranial Hypertension.

P2860

Q24187976-B6F27288-04DE-488E-8F70-AC638D04C523 Q26745691-54F58A59-D8F2-4EF3-AED2-2CD598645EF2 Q26765034-D463E150-EEFF-436F-8A5B-C9525BC48E9F Q26765260-7AA5F657-5B3C-4CEE-ACF3-75244DFAFA73 Q30356839-41D09784-82A0-4966-BC4F-3A56280AE5E7 Q30370124-12A5D564-8ADB-4452-A7AC-56E23BA61B99 Q30393845-5C2BB947-C45B-4B2F-9F2C-904C7D1767D5 Q31146225-15BEC138-52FF-4E39-956D-3B162883D715 Q33658064-E2B7DD66-BB02-4472-A6AF-9963C06B79C3 Q34091115-F343FB3D-2D56-4D27-BFCF-EE22EC638143 Q34700012-BF04331E-1C33-4E34-BC71-EA9F62A64762 Q35040672-E3EFC773-19CB-4FF8-B494-4246909C0CB8 Q35620366-3FBB4EB9-9A8F-48EC-8FA4-DD02853C7919 Q35620869-AD929341-6043-4796-B47A-2DF3101DF4C8 Q35771980-A4C91B27-E5E6-47F6-B0FB-C7CB357ABD86 Q35995529-C7960238-1339-4EF4-9865-4303E4AFED9A Q36005622-CF469C06-D429-45C3-9120-F2B186915D35 Q36035678-D5FFE66F-F96D-41B5-AF11-0AD99851BA2F Q36277112-7BEC35DA-DC31-4192-93C4-27BA3BFDD13C Q36383816-009BC56A-CF36-46CF-9E12-CEBBEDD98480 Q36420646-B6010BA0-10F0-402D-A80F-DBFC64220307 Q37244512-0738EA02-1DFB-49C5-9A42-9C30C2D6A61C Q37439414-9A4A4E97-A66E-49F7-846A-75CA2680CCD2 Q37439881-441715C2-3414-419F-AA97-5E6D633B3589 Q37577298-87007684-17F0-49B1-9996-5B24D8820BA5 Q37587255-1F420015-18DA-45A8-880B-F7BAF5C92106 Q38235629-387DCDE0-61DA-4981-BBB4-1684E29AC790 Q38236305-C9B1C33B-BF5B-4A90-8E8C-58FE41FF5E20 Q38285279-22650E4B-5293-42E7-A90A-D6116B22290C Q38543994-58CA1991-5038-4696-B51C-0E4F686DD823 Q38652472-95D92BCC-BEFD-4A94-A4B5-C010E9349E54 Q38731001-EE28BC4C-FB9C-485D-8B33-F451234F7128 Q38790994-63A6BE65-BB31-4124-B7F0-74AC5CE53780 Q38871789-7DC527A9-7E57-489C-B778-9583C4E0AF67 Q40016259-3D280C73-F843-4A08-AD4B-887884C0AA90 Q40400522-AC7069F2-9F23-4B10-B3DA-C06E506FF344 Q40481942-49F5BCB9-5C8C-404A-ACF2-7AB94B26A36F Q40501675-3495AB0D-4C8F-48A3-9799-21512BE0C4B7 Q41528844-6328A5C5-65D8-426D-B4EF-C3B782252960 Q41697808-328B670C-1E09-4AC3-815C-C00CE6575A81

P2860

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial

http://www.wikidata.org/entity/Q30407465

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effect of acetazolamide on vis ...... l hypertension treatment trial

@ast

Effect of acetazolamide on vis ...... l hypertension treatment trial

@en

type

label

Effect of acetazolamide on vis ...... l hypertension treatment trial

@ast

Effect of acetazolamide on vis ...... l hypertension treatment trial

@en

prefLabel

Effect of acetazolamide on vis ...... l hypertension treatment trial

@ast

Effect of acetazolamide on vis ...... l hypertension treatment trial

@en

P1433

Q30407465-CDE3A51B-99AF-4DD3-AA19-C87357325A29

P1476

Q30407465-400F1551-59F6-4F1D-B5DC-B6FDB4D79938

P2093

Q30407465-08017753-A100-4256-99B2-4E8643D254E3

Q30407465-0AF3BEE0-9C53-4C69-BF99-1F2A61C4ACF0

Q30407465-232249C7-2A2C-4ED7-9ABC-631A4544E303

Q30407465-2BB43D76-1590-4B6D-9F18-CA74520A3653

Q30407465-6BFF3A20-AA5A-409C-A9E4-0376A947F1CC

Q30407465-6D51FCCB-112E-4AB3-A5E6-2E3BF8A326EE

Q30407465-76DDA72E-AA74-46B8-A0E8-39638DC1742A

Q30407465-D9E2E6C6-F179-4BBA-BB95-FDB80254213C

Q30407465-DFC781A4-84FD-44FA-811C-2A3E0995333D

Q30407465-ECC3B766-C321-4729-8DAD-B3A6513BC694

P2860

Q30407465-0518A157-4217-4BF0-9DD9-17882AC48B37

Q30407465-19DDEE04-7B0A-4142-9BC3-256DAE048F15

Q30407465-2BADB0C6-4FD4-4E94-A5E7-7223F1E50152

Q30407465-5363D81D-8076-41C1-8C08-CF7DB573CF05

Q30407465-58CADBB7-BDCD-4062-9942-E4C844912F9E

Q30407465-5FA58040-7021-445E-9481-60E6154CA280

Q30407465-64EFA2F3-845B-49EC-AED9-A98ACC95D24A

Q30407465-6BB38901-AFC4-4EEB-97C1-C94E22C7CFF0

Q30407465-6DBF0DF0-EBC3-4C57-A6C9-10D24C9DC3BD

Q30407465-8D6FB7F5-DDD7-4B55-BCA4-1B698309DD35

P304

Q30407465-80835CC6-EAB6-4E53-B46A-573F87BD8BF1

P31

Q30407465-8D9AD94C-75D3-441C-8DF9-ADC65E09C5DE

P356

Q30407465-DFBB419C-977F-4B86-B989-79699DEC88C4

P407

Q30407465-380632B4-CADD-4478-8312-81943169CA8D

P433

Q30407465-87285A1E-1312-4B92-8356-6FC7579CED07

P478

Q30407465-E5A32773-3526-431C-BDA6-C4C71486D41A

P577

Q30407465-15F0934C-10AC-46A9-A4D5-3117E52D4573

P698

Q30407465-3A27A145-33CB-4FC7-8BF0-64C5F667CCC4

P921

Q30407465-08AFF0C6-B657-47D4-B9CE-713224EB94E2

Q30407465-C3A999AC-9E43-4896-ABB9-2213CEDD0ABD

P932

Q30407465-4DEEDC76-5A62-4D88-B558-7B8FE11DED8A

P356

P1433

Journal of the American Medical Association

P1476

Effect of acetazolamide on vis ...... l hypertension treatment trial

@en

P2093

David M Katz

http://www.w3.org/2001/XMLSchema#string

Deborah I Friedman

http://www.w3.org/2001/XMLSchema#string

Eleanor B Schron

http://www.w3.org/2001/XMLSchema#string

James J Corbett

http://www.w3.org/2001/XMLSchema#string

John L Keltner

http://www.w3.org/2001/XMLSchema#string

Karl D Kieburtz

http://www.w3.org/2001/XMLSchema#string

Mark J Kupersmith

http://www.w3.org/2001/XMLSchema#string

Michael P McDermott

http://www.w3.org/2001/XMLSchema#string

Michael Wall

http://www.w3.org/2001/XMLSchema#string

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for idiopathic intracranial hypertension

INTRACRANIAL PRESSURE WITHOUT BRAIN TUMOR: DIAGNOSIS AND TREATMENT

Swelling of the optic nerve head: a staging scheme

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline

Analyzing incomplete longitudinal clinical trial data.

Treatment of benign intracranial hypertension by dehydrating agents with particular reference to the measurement of the blind spot area as a means of recording improvement.

Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension.

Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale.

Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators.

Long-term intracranial pressure recording in the management of pseudotumor cerebri.

P304

1641-1651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2014.3312

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24756514

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

4362615

http://www.w3.org/2001/XMLSchema#string